---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-004362"
form_type: "8-K"
ticker: "SCND"
cik: "0000087802"
company_name: "SCIENTIFIC INDUSTRIES INC"
filed_at: "2024-04-08T23:59:59+00:00"
generated_at: "2026-06-04T01:37:39.501329+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Marcus Frampton resigns from Scientific Industries Board effective April 4, 2024

## Summary
- Marcus Frampton resigned as Class B Director by mutual agreement.
- Frampton had served as a director since March 2019.
- No replacement or further details disclosed in filing.

## SEC filing metadata
- accession: 0001654954-24-004362
- form_type: 8-K
- ticker: SCND
- cik: 0000087802
- company_name: SCIENTIFIC INDUSTRIES INC
- filed_at: 2024-04-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/87802/000165495424004362/0001654954-24-004362-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/87802/000165495424004362/scnd_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-004362
- JSON: https://secwatch.observer/filing/0001654954-24-004362.json
- Plain text: https://secwatch.observer/filing/0001654954-24-004362.txt

## Key facts
- Executive change
  Marcus Frampton resigned as Class B Director at SCIENTIFIC INDUSTRIES INC.
  - Action: resigned
  - Role: Class B Director
  source text: Effective April 4, 2024, by mutual agreement between the Company and Mr. Marcus Frampton, Mr. Frampton who had been appointed a Director of the Company in March 2019, resigned from his position as a Class B Director of the Company’s Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/87802/000165495424004362/0001654954-24-004362-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.